BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7184362)

  • 1. [Clinical effects of human fibroblast interferon on malignant tumors].
    Ezaki K; Okabe K; Inagaki J; Horikoshi N; Inoue K; Aiba K; Domyo M; Nagata T; Ogawa M
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):31-7. PubMed ID: 7184362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on the effect of human lymphoblastoid interferon in multiple myeloma].
    Takeyama H; Yano K; Kataoka T; Yamamoto M; Emi N; Kodera Y; Kawashima K; Ohno R; Yokomaku S; Kobayashi M
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2043-8. PubMed ID: 6614939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)].
    Ohno R; Kodera Y; Ogura M; Murase T; Emi N; Okumura M; Morishita Y; Nagura E; Minami S; Morishima Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2531-6. PubMed ID: 6594973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical trial of human lymphoblastoid interferon on advanced malignancy].
    Usui N; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Miyamoto H; Ikeda K; Nakada H; Adachi K; Okada Y
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2324-9. PubMed ID: 6357102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effects of human lymphoblastoid interferon in patients with hematologic neoplasms].
    Oda Y; Irie S; Inagaki M; Fukumoto M; Ueda I; Ohmoto E; Fujimoto S; Endo Y; Watanabe S; Lai M; Takahashi I; Kimura I; Ishii H; Sezaki T
    Gan To Kagaku Ryoho; 1983 May; 10(5):1313-9. PubMed ID: 6575725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of multiple myeloma with recombinant human leukocyte A interferon.
    Ohno R; Kimura K; Amaki I; Imamura Y; Masaoka T; Miyazaki T; Yoshida Y; Miura Y; Maekawa T; Oguro M
    Cancer Treat Rep; 1985 Dec; 69(12):1433-5. PubMed ID: 4075317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effect of human lymphoblastoid interferon in patients with multiple myeloma].
    Yoshida M; Ohta M; Muroi K; Takeda K; Kitagawa S; Tsuboyama A; Sakamoto S; Miura Y; Mutoh Y
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1394-8. PubMed ID: 6742866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of interferon on various malignancies].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and immunological studies of human fibroblast interferon and human lymphoblastoid interferon in malignant diseases].
    Ezaki K
    Gan No Rinsho; 1983 May; 29(6):598-602. PubMed ID: 6308306
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of a combination of human lymphoblastoid interferon (HLBI) and methyl-prednisolone (HLBI-mP) in multiple myeloma].
    Fukuzawa Y; Kawamura T; Ohno R
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3581-6. PubMed ID: 2817909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of human lymphoblastoid interferon in patients with multiple myeloma.
    Cox EB; Laszlo J; Krown S; Mintzer D; Sarna G
    J Biol Response Mod; 1988 Jun; 7(3):318-25. PubMed ID: 3392554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of non-hodgkin's lymphoma of low-grade malignancy with human fibroblast interferon.
    Siegert W; Theml H; Fink U; Emmerich B; Kaudewitz P; Huhn D; Böning L; Abb J; Joester KE; Bartl R; Riethmüller G; Wilmanns W
    Anticancer Res; 1982; 2(4):193-8. PubMed ID: 7149647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.
    Sarna G; Figlin R; McCarthy S
    J Biol Response Mod; 1983; 2(2):187-95. PubMed ID: 6644335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Introduction of natural interferon-alpha "Sumiferon"].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2800-3. PubMed ID: 3631977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha: current status and future promise.
    Bonnem EM; Spiegel RJ
    J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of human lymphoblast interferon in adult T-cell leukemia and non-Hodgkin's lymphoma].
    Kamihira S; Soda H; Kinoshita K; Ichimaru M
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2188-93. PubMed ID: 6605114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effect of human fibroblast interferon on malignant cancer. (2) Immunological study of the patients under treatment].
    Ezaki K; Okabe K; Domyo M; Abe K; Ogawa M
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):238-43. PubMed ID: 7184400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of soft tissue sarcoma with fibroblast interferon (beta-interferon): an American Cancer Society/Illinois Cancer Council Study.
    Harris J; Das Gupta T; Vogelzang N; Badrinath K; Bonomi P; Desser R; Locker G; Blough R; Johnson C
    Cancer Treat Rep; 1986 Feb; 70(2):293-4. PubMed ID: 3948193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.